Braskem SA BAK.N reported a quarterly adjusted loss of 2 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -27 cents. The mean expectation of three analysts for the quarter was for a loss of 61 cents per share. Wall Street expected results to range from -80 cents to -42 cents per share.
Revenue fell 9.1% to $2.98 billion from a year ago; analysts expected $3.19 billion.
Braskem SA's reported EPS for the quarter was a loss of $4.75.
The company reported a quarterly loss of $1.75 billion.
Braskem SA shares had risen by 33.6% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 46.6% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the commodity chemicals peer group is "buy."
Wall Street's median 12-month price target for Braskem SA is $3.50, about 12.6% below its last closing price of $3.94
This summary was machine generated from LSEG data March 27 at 11:48 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2025 | -0.90 | -0.02 | Beat |
Jun. 30 2025 | -0.83 | -0.02 | Beat |
Jun. 30 2025 | -0.83 | -0.14 | Beat |
Dec. 31 2024 | -0.81 | 0.30 | Beat |